Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases

The study compares the perceived treatment burden in patients undergoing intravitreal anti-VEGF treatment for either wet age related macular degeneration, macular edema after retinal vein occlusions or diabetic macular edema. This study is the first to the investigator's knowledge to compare treatment burden between all three patient groups, which also differ in age and socioeconomic circumstances. The results are of interest to all ophthalmologists who prescribe anti-VEGF treatments, as they show factors which can influence patient adherence und thus the efficacy of said therapies.

NCT Number	NCT07514559
Lead Sponsor	Hospital Hietzing Collaborators: Scientific fund of the City of Vienna
Conditions	Age Related Macular Degeneration (ARMD), Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME)
Enrollment	393 participants
Start Date	2023-05-01
Primary Completion	2024-04-30 (estimated)
Study Completion	2024-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-07